UNSPSC 85891145: High dose rate (hdr) brachytherapy of brain using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of brain using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D0109BZ

UNSPSC 85891145 High dose rate (hdr) brachytherapy of brain using palladium 103 (pd-103) is a Commodity code that shows minimal relevant recent state and local procurement activity. The single posted opportunity under this code—a Santa Clara County Health System RFQ for temporary health professional staffing services issued July 7, 2026, with a response deadline of October 7, 2026—does not align with the code's stated scope of radiotherapy treatment. The Santa Clara solicitation establishes a qualified vendor pool for temporary clinical staffing across ancillary categories including audiology, diagnostic imaging, respiratory care, and surgical support, explicitly excluding nursing and physician services. While diagnostic imaging and related modalities may tangentially touch oncology workflows, the procurement is fundamentally a staffing services vehicle rather than a specialized brachytherapy service or product line.

The mismatch between the code's nominal scope and the actual opportunity suggests either a classification error in the state or local procurement system or that brachytherapy services under this specific isotope and treatment protocol do not generate regular solicitation volume at the state and local level. No additional recent opportunities appear in the dataset. Business development professionals should verify whether this code is actively used by health systems and cancer treatment centers in their target regions before investing pursue effort; if activity does exist, it is not surfacing in current state and local procurement channels tracked here.